Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

07. Oktober 2015 07:30 ET | Quelle: Dermira, Inc.

Dermira Presents Data From DRM01 Phase 2a Trial at European Academy of Dermatology and Venereology

MENLO PARK, Calif., Oct. 7, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and...
02. Juni 2015 07:30 ET | Quelle: Dermira, Inc.

Dermira Announces Poster Presentation on DRM01 in Acne at World Congress of Dermatology

MENLO PARK, Calif., June 2, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and...
23. März 2015 07:00 ET | Quelle: Dermira, Inc.

Clinical Data for Dermira's DRM01 Acne Program Presented at Dermatology Meeting

MENLO PARK, Calif., March 23, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists...